33 related articles for article (PubMed ID: 12506482)
1. Salvage gastrectomy following a combination of biweekly paclitaxel and S-1 for stage IV gastric cancer.
Ishigami S; Natsugoe S; Nakajo A; Matsumoto M; Uenosono Y; Arigami T; Setoyama T; Arima H; Uchikado Y; Kita Y; Sasaki K; Aikou T
J Gastrointest Surg; 2008 Aug; 12(8):1370-5. PubMed ID: 18516651
[TBL] [Abstract][Full Text] [Related]
2. Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1.
Arai W; Hosoya Y; Hyodo M; Haruta H; Kurashina K; Saito S; Hirashima Y; Yokoyama T; Zuiki T; Sakuma K; Yasuda Y; Nagai H
Int J Clin Oncol; 2007 Apr; 12(2):146-9. PubMed ID: 17443283
[TBL] [Abstract][Full Text] [Related]
3. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
[TBL] [Abstract][Full Text] [Related]
4. [Low-dose paclitaxel therapy as second-line chemotherapy for patients who previously received TS-1 therapy].
Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2183-6. PubMed ID: 15628768
[TBL] [Abstract][Full Text] [Related]
5. [Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
Makari Y; Fujiwara Y; Yasuda T; Takiguchi S; Kimura Y; Yano M; Monden M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):609-11. PubMed ID: 15114710
[TBL] [Abstract][Full Text] [Related]
6. [A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
Jingu K; Sasagawa K; Kagaya A; Ochiai T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2117-20. PubMed ID: 16352940
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
[TBL] [Abstract][Full Text] [Related]
8. [Three cases of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration].
Fujiwara Y; Tamura S; Yoshioka S; Okada Y; Takiguchi S; Yano M; Yasuda T; Monden M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2555-9. PubMed ID: 12506482
[TBL] [Abstract][Full Text] [Related]
9. [Weekly administration of paclitaxel with a short course of premedication for advanced or recurrent gastric cancer].
Yamamoto S; Tanaka Y; Ito T; Nakai S; Morimoto Y; Kitagawa T; Kurihara Y; Nishimura J
Gan To Kagaku Ryoho; 2003 Jan; 30(1):67-71. PubMed ID: 12557707
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of pre-operative administration of TS-1 in patients with advanced gastric or colorectal cancer--estimation of pathological effectiveness for postoperative adjuvant chemotherapy with TS-1].
Nakano K; Koizumi H; Okugawa K; Nakamura K; Osaka Y; Tsuchiya K; Sako H; Tanabe S; Nakane Y
Gan To Kagaku Ryoho; 2005 Mar; 32(3):329-33. PubMed ID: 15791815
[TBL] [Abstract][Full Text] [Related]
11. [Current combination chemotherapy containing paclitaxel for advanced, recurrent gastric cancer].
Emi Y; Kakeji Y; Baba H; Ishida T; Maehara Y
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1978-81. PubMed ID: 15570924
[TBL] [Abstract][Full Text] [Related]
12. [TS-1 therapy for advanced gastric cancer].
Kurihara M; Koizumi W; Hasegawa K; Sakata Y; Ohtsu A; Taguchi T
Nihon Rinsho; 2001 Apr; 59 Suppl 4():393-7. PubMed ID: 11424413
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
